Drugs / L-Ascorbate
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04800692 | Jun 2021 → Jul 2027 expected | intermittent vascular claudication, peripheral arterial disease | Louis Messina | Active not recruiting | No outcome recorded |
| Phase 1 | NCT02966665 | Sep 2008 → Aug 2030 expected | chronic obstructive pulmonary disease, heart failure, pulmonary arterial hypertension | D. Walter Wray | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | L-Ascorbate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02966665 ↗ |